scholarly journals A Mathematical Model of Hepatitis A Transmission in the United States Indicates Value of Universal Childhood Immunization

2006 ◽  
Vol 43 (2) ◽  
pp. 158-164 ◽  
Author(s):  
Thierry P. Van Effelterre ◽  
Thomas K. Zink ◽  
Bernard J. Hoet ◽  
William P Hausdorff ◽  
Philip Rosenthal
Keyword(s):  
United States ◽  
Mathematical Model ◽  
Hepatitis A ◽  
The United States ◽  
Childhood Immunization ◽  
Hepatitis A Transmission

Viral Hepatitis A

2021 ◽  
Author(s):  
Kenrad E Nelson ◽  
Brittany L Kmush
Keyword(s):  
United States ◽  
Acute Hepatitis ◽  
Injection Drug Users ◽  
Drug Users ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Severe Disease ◽  
The United States ◽  
Childhood Immunization ◽  
Effective Prevention

Epidemics of infectious jaundice have been reported throughout recorded history. However, the proof that many of these outbreaks and individual cases of acute hepatitis were caused by a viral infection, the hepatitis A virus (HAV), did not appear until the 1960s. After the transmission of infection to marmosets and humans, the epidemiologic and virologic characteristics that differed between hepatitis A and hepatitis B virus infections were defined more clearly. After the development and licensure of hepatitis A vaccines in the 1990s, it became possible to implement an effective prevention program involving routine immunization of young children in the United States and several other Western countries. However, despite the dramatic efficacy of the childhood immunization program in reducing the incidence of acute hepatitis from HAV in the population, older children and adults remained susceptible. Significant morbidity continues to occur in the United States among international travelers, injection drug users, persons with underlying liver disease, and other high-risk populations. Since HAV is a global pathogen, the prevention of increasing morbidity from hepatitis A attributable to the incidence of clinically more severe disease increases in countries transitioning from high to intermediate or low endemic status is a major public health challenge. In this review, we discuss the epidemiology, virology, clinical characteristics, and prevention of hepatitis A infections. This review contains 8 figures, 3 tables and 89 references Key words: epidemiology, global impact, hepatitis A vaccine, hepatitis A virus, prevention, reservoirs, risk factors, treatment

Viral Hepatitis A

2021 ◽  
Author(s):  
Kenrad E Nelson ◽  
Brittany L Kmush
Keyword(s):  
United States ◽  
Acute Hepatitis ◽  
Injection Drug Users ◽  
Drug Users ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Severe Disease ◽  
The United States ◽  
Childhood Immunization ◽  
Effective Prevention

Epidemics of infectious jaundice have been reported throughout recorded history. However, the proof that many of these outbreaks and individual cases of acute hepatitis were caused by a viral infection, the hepatitis A virus (HAV), did not appear until the 1960s. After the transmission of infection to marmosets and humans, the epidemiologic and virologic characteristics that differed between hepatitis A and hepatitis B virus infections were defined more clearly. After the development and licensure of hepatitis A vaccines in the 1990s, it became possible to implement an effective prevention program involving routine immunization of young children in the United States and several other Western countries. However, despite the dramatic efficacy of the childhood immunization program in reducing the incidence of acute hepatitis from HAV in the population, older children and adults remained susceptible. Significant morbidity continues to occur in the United States among international travelers, injection drug users, persons with underlying liver disease, and other high-risk populations. Since HAV is a global pathogen, the prevention of increasing morbidity from hepatitis A attributable to the incidence of clinically more severe disease increases in countries transitioning from high to intermediate or low endemic status is a major public health challenge. In this review, we discuss the epidemiology, virology, clinical characteristics, and prevention of hepatitis A infections. This review contains 8 figures, 3 tables and 89 references Key words: epidemiology, global impact, hepatitis A vaccine, hepatitis A virus, prevention, reservoirs, risk factors, treatment

Viral Hepatitis A

2021 ◽  
Author(s):  
Kenrad E Nelson ◽  
Brittany L Kmush
Keyword(s):  
United States ◽  
Acute Hepatitis ◽  
Injection Drug Users ◽  
Drug Users ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Severe Disease ◽  
The United States ◽  
Childhood Immunization ◽  
Effective Prevention

Epidemics of infectious jaundice have been reported throughout recorded history. However, the proof that many of these outbreaks and individual cases of acute hepatitis were caused by a viral infection, the hepatitis A virus (HAV), did not appear until the 1960s. After the transmission of infection to marmosets and humans, the epidemiologic and virologic characteristics that differed between hepatitis A and hepatitis B virus infections were defined more clearly. After the development and licensure of hepatitis A vaccines in the 1990s, it became possible to implement an effective prevention program involving routine immunization of young children in the United States and several other Western countries. However, despite the dramatic efficacy of the childhood immunization program in reducing the incidence of acute hepatitis from HAV in the population, older children and adults remained susceptible. Significant morbidity continues to occur in the United States among international travelers, injection drug users, persons with underlying liver disease, and other high-risk populations. Since HAV is a global pathogen, the prevention of increasing morbidity from hepatitis A attributable to the incidence of clinically more severe disease increases in countries transitioning from high to intermediate or low endemic status is a major public health challenge. In this review, we discuss the epidemiology, virology, clinical characteristics, and prevention of hepatitis A infections. This review contains 8 figures, 3 tables and 89 references Key words: epidemiology, global impact, hepatitis A vaccine, hepatitis A virus, prevention, reservoirs, risk factors, treatment

Viral Hepatitis A

2021 ◽  
Author(s):  
Kenrad E Nelson ◽  
Brittany L Kmush
Keyword(s):  
United States ◽  
Acute Hepatitis ◽  
Injection Drug Users ◽  
Drug Users ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Severe Disease ◽  
The United States ◽  
Childhood Immunization ◽  
Effective Prevention

Epidemics of infectious jaundice have been reported throughout recorded history. However, the proof that many of these outbreaks and individual cases of acute hepatitis were caused by a viral infection, the hepatitis A virus (HAV), did not appear until the 1960s. After the transmission of infection to marmosets and humans, the epidemiologic and virologic characteristics that differed between hepatitis A and hepatitis B virus infections were defined more clearly. After the development and licensure of hepatitis A vaccines in the 1990s, it became possible to implement an effective prevention program involving routine immunization of young children in the United States and several other Western countries. However, despite the dramatic efficacy of the childhood immunization program in reducing the incidence of acute hepatitis from HAV in the population, older children and adults remained susceptible. Significant morbidity continues to occur in the United States among international travelers, injection drug users, persons with underlying liver disease, and other high-risk populations. Since HAV is a global pathogen, the prevention of increasing morbidity from hepatitis A attributable to the incidence of clinically more severe disease increases in countries transitioning from high to intermediate or low endemic status is a major public health challenge. In this review, we discuss the epidemiology, virology, clinical characteristics, and prevention of hepatitis A infections. This review contains 8 figures, 3 tables and 89 references Key words: epidemiology, global impact, hepatitis A vaccine, hepatitis A virus, prevention, reservoirs, risk factors, treatment

Hepatitis A virus infections associated with clotting factor concentrate in the United States

Transfusion ◽  
1998 ◽  
Vol 38 (6) ◽  
pp. 573-579 ◽  
Author(s):  
JM Soucie ◽  
BH Robertson ◽  
BP Bell ◽  
KA McCaustland ◽  
BL Evatt
Keyword(s):  
United States ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
The United States ◽  
Clotting Factor ◽  
Virus Infections ◽  
Factor Concentrate

Outbreaks of Shellfish-Associated Enteric Virus Illness in the United States: Requisite for Development of Viral Guidelines

1985 ◽  
Vol 48 (9) ◽  
pp. 815-823 ◽  
Author(s):  
GARY P. RICHARDS
Keyword(s):  
United States ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Enteric Virus ◽  
The United States ◽  
Viral Gastroenteritis ◽  
Norwalk Virus ◽  
Virus Contamination ◽  
Pathogenic Viruses

Outbreaks of hepatitis A, Norwalk illness, and nonspecific viral gastroenteritis are associated with consumption of sewage-contaminated shellfish. Over 100 outbreaks have been reported in the United States during the past 50 years. Reported cases of shellfish-associated enteric virus illness are on the increase, whereas bacterial illness from shellfish is on the decline. As yet, there are no procedures for detecting hepatitis A virus, Norwalk virus and numerous other pathogenic viruses in environmental samples, but virus extraction and assay procedures for water and shellfish are available for the more easily cultivated enteric viruses. Current standards rely on bacterial indicators as a means to evaluate the sanitary quality of shellfish and their growing waters, but the adequacy of using bacteria as indicators of possible virus contamination is questionable. The feasibility of employing enteroviruses or rotaviruses as possible viral indiators is discussed. It is proposed that easily cultivated enteroviruses, such as poliovirus, be used as an interim indicator for the possible presence of human pathogenic viruses in seafoods, with the subsequent formulation of guidelines to limit the levels of virus contamination in shellfish.

scholarly journals Hepatitis A hospitalizations in the United States, 2002-2011

Hepatology ◽  
2015 ◽  
Vol 61 (2) ◽  
pp. 481-485 ◽  
Author(s):  
Melissa G. Collier ◽  
Xin Tong ◽  
Fujie Xu
Keyword(s):  
United States ◽  
Hepatitis A ◽  
The United States

Hepatitis A Virus Transmission by Blood Products in the United States

Vox Sanguinis ◽  
1994 ◽  
Vol 67 (1) ◽  
pp. 24-28 ◽  
Author(s):  
James W. Mosley ◽  
Marek J. Nowicki ◽  
Carol K. Kasper ◽  
Elizabeth Donegan ◽  
Louis M. Aledort ◽  
...  
Keyword(s):  
United States ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Virus Transmission ◽  
The United States ◽  
Blood Products

scholarly journals Susceptibility to Hepatitis A Virus Infection in the United States, 2007–2016

2020 ◽  
Vol 71 (10) ◽  
pp. e571-e579 ◽  
Author(s):  
Shaoman Yin ◽  
Laurie Barker ◽  
Kathleen N Ly ◽  
Greta Kilmer ◽  
Monique A Foster ◽  
...  
Keyword(s):  
United States ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Risk Groups ◽  
The United States ◽  
Poverty Level ◽  
Health And Nutrition ◽  
National Immunization ◽  
Vaccination Recommendations ◽  
Sex With Men

Abstract Background Despite national immunization efforts, including universal childhood hepatitis A (HepA) vaccination recommendations in 2006, hepatitis A virus (HAV)–associated outbreaks have increased in the United States. Unvaccinated or previously uninfected persons are susceptible to HAV infection, yet the susceptibility in the US population is not well known. Methods Using National Health and Nutrition Examination Survey 2007–2016 data, we estimated HAV susceptibility prevalence (total HAV antibody negative) among persons aged ≥2 years. Among US-born adults aged ≥20 years, we examined prevalence, predictors, and age-adjusted trends of HAV susceptibility by sociodemographic characteristics. We assessed HAV susceptibility and self-reported nonvaccination to HepA among risk groups and the “immunization cohort” (those born in or after 2004). Results Among US-born adults aged ≥20 years, HAV susceptibility prevalence was 74.1% (95% confidence interval, 72.9–75.3%) during 2007–2016. Predictors of HAV susceptibility were age group 30–49 years, non-Hispanic white/black, 130% above the poverty level, and no health insurance. Prevalences of HAV susceptibility and nonvaccination to HepA, respectively, were 72.9% and 73.1% among persons who reported injection drug use, 67.5% and 65.2% among men who had sex with men, 55.2% and 75.1% among persons with hepatitis B or hepatitis C, and 22.6% and 25.9% among the immunization cohort. Susceptibility and nonvaccination decreased over time among the immunization cohort but remained stable among risk groups. Conclusions During 2007–2016, approximately three-fourths of US-born adults remained HAV susceptible. Enhanced vaccination efforts are critically needed, particularly targeting adults at highest risk for HAV infection, to mitigate the current outbreaks.

Sign in / Sign up

Export Citation Format

Share Document